Table 13.12

Unadjusted Patient Survival, Heart-Lung Transplants

Survival at 3 Months, 1 Year, 3 Years, and 5 Years

  3 Months 1 Year 3 Years 5 Years
(Tx 2002 - 2003) (Tx 2002 - 2003) (Tx 2000 - 2003) (Tx 1998 - 2003)
N % Std. Err. N % Std. Err. N % Std. Err. N % Std. Err.
Total All 57 70.2% 6.1% 57 57.9% 6.5% 130 52.1% 4.6% 222 40.2% 3.8%
Primary Diagnosis Congenital Disease 19 68.4% 10.7% 19 47.4% 11.5% 50 49.1% 7.5% 85 38.6% 6.4%
Primary Pulmonary Hypertension 17 76.5% 10.3% 17 76.5% 10.3% 32 67.0% 8.7% 50 54.1% 7.7%
Cystic Fibrosis 2 50.0% 35.4% 2 50.0% 35.4% 2 + + 4 + +
Emphysema/COPD 0 - - 0 - - 3 33.3% 27.2% 10 60.0% 15.5%
Other 3 66.7% 27.2% 3 66.7% 27.2% 9 0.0% 0.0% 14 0.0% 0.0%
Unknown 16 68.8% 11.6% 16 50.0% 12.5% 34 55.9% 8.5% 59 37.8% 6.8%


Source: OPTN/SRTR Data as of May 2, 2005.

(+) = Values not determined due to insufficient follow-up.

(-) = Values not determined since there were no transplants in the category.

Cohorts are transplants performed during the years listed at the top of the table.

Patient survival follows patients from first transplant of this type until death.Counts for patient and graft survival are different because a patient may have more than one transplant for a type of organ.

Center volume = Center's yearly transplants performed during the base period, based on heart-lung transplants.

Multi-organ transplants are excluded.